Received on 06 June 2022; revised on 09 August 2022; accepted on 11 August 2022
Staphylococcus aureus remains the most virulent pathogenic staphylococcal species known to human beings. Oxacillin is still the best antibiotic used for treating infections with S. aureus. However, cases of resistance are increasingly recorded and cause a serious public health concern. The objective of this study was to evaluate the resistance of S. aureus to oxacillin. The study was carried out in the North region of Cameroon on strains isolated at Centre Pasteur in Cameroon. Three hundred (300) strains of Staphylococcus were recorded, among them 200 (66.67%) were identified as Staphylococcus aureus, mainly coming from six (06) different types of samples. The susceptibility test to oxacillin was carried out using two methods: the diffusion method using discs (oxacillin, cefoxitin) and the determination of Minimum Inhibition Concentration (MIC) by E-test. Overall 84 (42%) resistant strains were detected by both methods. Cervico-vaginal specimen harbored the highest number of S. aureus strains (41%), compared to other specimen types. However, pus recorded the highest number of resistant cases (79%), followed by semen culture (50%). Among all resistant strains recorded, 84.5% were tested positive for beta-lactamase production.
Staphylococcus aureus; Methicillin resistance; Oxacillin resistance; Resistance rate; Beta-lactamase production
⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.